Transcript Highlights:

• patient than a commercial patient.
• Commercial patient data, right?
• final call on the patient.
• The patients didn’t catch it.
• Patients are not mere data points.

Summary: The joint informational hearing of the Assembly Health and Privacy Committees focused on generative AI in health care, with opening remarks emphasizing both its potential to improve care and its risks around privacy, bias, liability, workforce impacts, and unequal access. Chair Bauer-Kahan and Chair Bonta framed the discussion around how California can encourage beneficial innovation while protecting patients, especially given the sensitivity of health data and the possibility that AI could worsen existing disparities if not carefully governed. The first panel featured representatives from Cedars-Sinai, Kaiser Permanente, Penguin AI, and Google, who described current uses of AI such as ambient clinical scribes, nursing documentation tools, imaging triage, maternal-fetal risk prediction, and administrative automation. Speakers said these tools can reduce clinician burden, improve patient experience, speed treatment, and in some cases improve outcomes, including a reported mortality benefit from a Kaiser predictive model and faster thrombectomy times at Cedars-Sinai. Members raised concerns about accuracy with accents and multilingual visits, whether predictive tools could reinforce bias or lead to more interventions such as C-sections, and how to ensure a human remains in the loop for important decisions. The second panel, including representatives from the California Health Care Foundation, UC Berkeley, and Stanford, focused on policy and governance challenges. Testimony highlighted examples of AI supporting homelessness outreach and community health work, but also warned that biased algorithms can encode inequities, especially when trained on data that reflect under-treatment of Black, rural, or low-income patients. Witnesses urged clearer standards for trustworthy AI, stronger monitoring and governance structures, better data access for accountability, and attention to the safety net’s limited resources. Several speakers argued that states should require health systems to have AI governance processes, clarify liability between developers and deployers, and regulate downstream uses of AI while preserving access to data for lifesaving research and oversight.

Transcript Highlights:

• Each one of our patients was handled through the process, through proactive physician engagement, patient
• Each one of our patients was handled through the process, through proactive physician engagement, patient
• That's not a patient that I would want to switch.
• And if I've had a patient that I've had to try many different medications, and I do, Had a patient that
• And I just repeat again: imagine you are a patient that... ...again, imagine you are a patient that qualified

Summary: The committee heard several bills, beginning with SB 1312 by Senator Richardson on abandoned endowed-care cemeteries. Richardson described vandalism, theft, and neglect at abandoned cemeteries and said the bill would define abandonment, create a process for local governments to declare a cemetery abandoned, and allow the Bureau to act as conservator of endowment funds. Support came from Marin County, while county and special district groups opposed or had concerns, arguing the bill could shift burdens to local governments or public cemetery districts without enough safeguards. Members expressed general support but noted the need for further work; the bill was discussed but no final vote was taken in the excerpt. The committee then took up SB 758 by Senator Umberg, which would restrict retail sales of nitrous oxide to curb misuse. Supporters, including the League of California Cities, narcotic officers, counties, pediatricians, and other local governments and health groups, said easy access at smoke shops and convenience stores has fueled recreational abuse and health harms. There was no opposition testimony, and members voiced strong support for a statewide approach over city-by-city bans. The bill was well received, with the author closing in support. Dr. Weber-Pierson presented SB 1094, a health care affordability bill on biosimilars and biologic substitution. The bill would allow pharmacists to substitute biosimilars under certain conditions, require advance notice to providers and patients, and add reporting on savings; the author said amendments would strengthen provider notice and preserve the ability to mark prescriptions “do not substitute.” Supporters from health plans, insurers, pharmacies, labor, business, and some provider groups argued the bill would lower costs and expand access. Opponents, including dermatology and rheumatology groups and biotech interests, warned about non-medical switching, prior authorization delays, and patient harm. After extensive discussion, the committee voted 13-0 to pass SB 1094 to the Committee on Health. The committee also passed SB 849 by Dr. Weber-Pierson, which would bar reinstatement of physicians who surrendered their licenses while a sexual misconduct accusation was pending. The Medical Board and California Medical Association were generally supportive or neutral, and members praised the bill’s patient-protection focus. SB 993 by Senator Ochoa Bogh, which limits routine disclosure of identifying information for mental health professionals in correctional and psychiatric settings while preserving complaint processes, also passed unanimously to Appropriations. SB 1002 by Senator Niello, extending the David Hall Act to allow certain patients in remission to continue telehealth care with out-of-state specialists, drew strong patient support but opposition from the Medical Board and CMA over licensure and oversight concerns; the committee voted it out on a split roll with some members not voting. Finally, SB 1263 by Senator McGuire, aimed at protecting wildfire survivors and workers by requiring licensed, trained contractors for post-disaster residential debris removal, received support from labor and the Contractors State License Board, with contractors raising a narrower amendment concern about scope.

Transcript Highlights:

• Our patients in your constituents shouldn't be treated differently than patients in other states.
• Our patients in your constituents shouldn't be treated differently than patients in other states.
• , but other patients as well.
• , but other patients as well.
• </c><00:38:28.880><c> so</c> prescription drugs for patients so prescription drugs for patients so patient

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• Patients and doctors have to navigate this maze initially, and then again and again if the patient changes
• Patients and doctors have to navigate this maze initially, and then again and again, if the patient changes
• For cancer patients, time is of the essence.
• You know, we sometimes consider whether we work with the patient or don't work with the patient.
• But more concerning is the impact on patients.

Committee: Joint Joint Committee on Financial Services

Summary: The committee held a hearing on several health care access and insurance-related bills, with most testimony focused on H.1136 to improve the prior authorization process. The Massachusetts Medical Society, Massachusetts Health and Hospital Association, Health Care for All, the Leukemia & Lymphoma Society, physicians, and hospital representatives all supported the bill, arguing that prior authorization delays care, increases administrative burden, contributes to clinician burnout, and can worsen patient outcomes. Witnesses described examples involving delayed cancer treatment, diabetes care, COPD medication, shingles pain treatment, and hospital discharge delays. They said the bill would preserve prior authorization but add guardrails such as longer validity periods, continuity-of-care protections, faster responses for urgent care, clearer lists of services requiring authorization, and more transparency and standardization. The committee also heard testimony on H.1142/S.783 regarding equitable reimbursement for certified registered nurse anesthetists (CRNAs), with Senator Lovely and CRNA advocates supporting parity with physician anesthesiologists. They said CRNAs provide the same services at the same standard of care, but private insurers sometimes reimburse them at lower rates than physicians, which they argued is inconsistent with federal and state policy and harms access. Senator Keenan testified in support of a bill addressing claim denials and appeals, saying insurers should provide clearer explanations, time to resubmit claims, and timely appeal responses. Dr. Lorraine Schratz supported H.1126 to align state patient disclosure requirements with federal No Surprises Act rules, and Dr. Michael Trimbley supported H.1120 to recognize direct primary care as not being insurance and to encourage primary care participation. The committee also heard testimony on H.1140/S.801 to remove barriers to patient care by updating insurance statutes to reflect nurse practitioners’ full practice authority, and on H.1168/S.A.18 to eliminate the PCP referral requirement for specialty gynecological care. Witnesses on those bills described delays and denials affecting autism diagnosis, nutrition coverage, and endometriosis care, and said the proposals would reduce unnecessary barriers and improve timely access. After testimony and a few member questions, the chair closed the hearing; no votes were taken during the session.

Transcript Highlights:

• the patient.
• It gives patients control over records.
• greater patient engagement.
• It gives patient control over records.
• greater patient engagement.

Summary: The subcommittee met with a quorum present and took up five health-related bills. HB 1089, which would add Duchenne muscular dystrophy to Florida’s newborn screening panel, was presented as a way to enable earlier diagnosis and treatment; a pediatric neurologist from Nemours testified in support, noting existing FDA-approved therapies and ongoing clinical trials. After supportive debate, the bill passed 17-0 and was reported favorably. HB 1083 would standardize patient access to medical records by setting deadlines for providers to produce or allow inspection of records and requiring electronic delivery when available. Supporters said it would reduce delays in care and costs, while two industry groups appeared in opposition. Members from both parties spoke in favor, and the bill passed 17-0 and was reported favorably. HB 1297, which aligns Florida’s electronic prescribing rules more closely with federal law and removes some state exceptions, drew opposition from physicians who argued paper prescriptions are still needed for emergencies, shortages, and price shopping. The sponsor said the bill’s goals were patient safety, fraud prevention, and efficiency; despite concerns, it passed 18-0 and was reported favorably. The committee then considered PCS for HB 1421, the Emily Adkins Family Protection Act, which would create a statewide blood clot and pulmonary embolism registry, require hospital reporting and risk-assessment policies, and expand training requirements in hospitals, nursing homes, and assisted living facilities. The bill was presented with emotional testimony from Emily Adkins’ parents, who urged support and co-sponsorship in her memory. Members from both parties praised the family’s advocacy, and the PCS passed 18-0 and was reported favorably. Finally, HB 449 on optometry would expand optometrists’ authority to prescribe certain medications and perform specified laser and non-laser eye procedures after certification. The bill and amendment drew strong opposition from ophthalmologists and their association, who raised patient-safety, training, and delegation concerns, while optometrists argued the bill would improve access, especially in rural areas and counties without ophthalmologists. The amendment was adopted, and the bill as amended passed on a recorded vote and was reported favorably.

Transcript Highlights:

• The drug to the patient.
• Patients are not... I'm not having that patient... ...should come in and see me.
• Patients after that.
• with the patients.
• in their patient mix.

Bills: HB46 , HB35 , HB4490 , HB4454 , HB2188 , HB3078 , HB4743 , HB2556 , HB46 , HB5342 , HB4783 , HB3785 , HB5278 , HB1639 , HB2581 , HB4224 , HB4070 , HB4099 , HB4882 , HB3794

Committee: House Public Health

Transcript Highlights:

• You make a happier patient. You make a patient that can come to work and be productive.
• But the indirect patient benefits, you provide a safety net. If you will, for 340B patients.
• Now, he's not a hospital patient.
• patients are underinsured.
• choices and patient steering.

Bills: HB712 , HB722 , HB946 , HB1687 , HB1809 , HB1899 , HB2528 , HB2583 , HB2741 , HB2750 , HB3021 , HB3150 , HB3265 , HB3658 , HB3812 , HB3960 , HB4392 , HB4432

Committee: House Insurance

Transcript Highlights:

• , time, and stress for patients.
• Additionally, it harms patients, as I saw a patient who had a lung cancer screening test denied for many
• We care for 300 patients instead of 3,000 patients, and each visit lasts as long as needed, sometimes
• We care for 300 patients instead of 3,000 patients, and each visits last as long as needed, sometimes
• patients we care for every day.

Committee: Joint Joint Committee on Financial Services

Summary: The committee held a public hearing with testimony on several health care bills, with most of the discussion focused on primary care access, community health center reimbursement, midwifery and birth centers, telehealth, hospital-at-home, direct primary care, and trans-inclusive health care access. Chair Feeney and Chair Murphy opened by noting the large number of signups and asking testifiers to keep remarks brief because of time constraints. Legislators and witnesses repeatedly emphasized that Massachusetts’ primary care system is under strain and that federal policy changes and reimbursement gaps are worsening financial pressure on providers. On community health centers, Representative Blay, Senator Lovely, Michael Curry, Bethany Keeley, Jag Deep Trevetti, Sean Cahill, and Christina Severin all supported H. 1096/S. 711, which would require commercial insurers to pay federally qualified health centers at least the MassHealth prospective payment system rate. They argued that commercial plans currently reimburse health centers below Medicaid rates, threatening sustainability, staffing, and access, especially as federal cuts and coverage losses could increase uncompensated care. Testifiers said the bill would stabilize health centers, protect primary care access, and not cost the state money. A second major topic was H. 1117/S. 784 on sustaining birth centers and the midwifery workforce. Senator Lovely, Senator Miranda, Emily Anesta, Rebecca Orden, Catherine Rushworth, Nishira Burrill, Joel Sutherland, Rachel Blessington, Joelle Ward, and others described the 2024 maternal health omnibus as an important first step, but said birth centers and midwives still face low reimbursement, workforce shortages, and financial instability. They urged reimbursement parity, a workforce development fund, and support for freestanding birth centers, citing improved outcomes, lower C-section rates, better patient experience, and racial equity in maternal health. Several speakers shared personal birth stories and said the bill would help preserve and expand birth options in communities like Roxbury, Worcester, and the North Shore. The committee also heard support for H. 1343 on direct primary care from Dr. Garofalo, Dr. Altman, Dr. Nair, Stephanie Cameron, Dr. Haley Moke-Blessed, and others, who said current insurance rules force patients to use a separate in-network primary care doctor for referrals and sometimes prevent physicians from dispensing medications. They argued the bill would reduce delays, administrative burden, and costs while improving continuity of care. In addition, Dr. Miklides and Sue Stempeck supported H. 1141 on hospital-at-home parity, saying the model has strong outcomes and should be reimbursed at the same rate as brick-and-mortar hospital care. Heather Myers and Katrina Cook testified on telehealth and digital health equity, urging broader coverage for asynchronous care, remote monitoring, interpreter services, and digital literacy supports. SEIU Local 509 supported H. 1188/S. 681 on trans-inclusive health care access, saying it would remove arbitrary insurance barriers to gender-affirming care. No votes or committee actions were taken during the hearing.

Transcript Highlights:

• therapeutic cannabis patients many therapeutic cannabis patients<00:08:07.280><c> actively</c><00:08
• And that's important to our patients because cost is a very important barrier for many of our patients
• </c> the time we certainly hear from patients the time we certainly hear from patients patients<01:35
• </c><01:36:09.840><c> to</c> the patient side would allow patients to the patient side would allow patients
• </c> patients that face that burden patients patients that face that burden patients of<02:02:29.280>

Committee: House Health, Human Services & Elderly Affairs

Transcript Highlights:

• Here's what patients need to know.
• for Patient Safety.
• Patients understand that.
• and patient safety.
• care. weakening patient care and patient safety.

Summary: The committee held public hearings on House Bill 2261, which would require health care providers to wear badges showing name, credential, and relevant degrees, require similar disclosure in advertising, and restrict use of the title “physician surgeon” to certain physicians and osteopathic physicians. Supporters, including the Washington State Medical Association and patient advocates, said the bill would improve transparency and informed consent. Opponents from nurse, naturopathic, and adult family home groups argued it was overly broad, burdensome, confusing, and could harm access to care or residential home settings; several also said existing disciplinary laws already address misrepresentation. No vote was taken on HB 2261 during the hearing. The committee also heard House Bill 2283, which would raise the medical loss ratio for fully insured individual, small group, and large group health plans to 90 percent. Supporters, including small business, patient, and physician groups, said the bill would push more premium dollars toward patient care and lower costs or increase rebates. Insurers and the Office of the Insurance Commissioner warned it could destabilize the market, reduce flexibility for administrative services, and lead to carrier exits, though OIC said it was working on amendments. The bill was not voted on in the hearing. House Bill 2425, an agency-request bill on nurse delegation, would broaden what tasks registered nurses may delegate, remove some setting and training restrictions, expand emergency medication authority, and adjust liability and retaliation protections. The Board of Nursing, long-term care providers, and skilled nursing/assisted living representatives supported the bill as a modernization that could ease workforce shortages and improve care access, while the Washington State Association for Justice opposed the immunity provisions and raised patient safety concerns. The hearing ended without a vote on HB 2425. In executive session, the committee advanced several bills. HB 2110, with an amendment clarifying ambulance staffing and RN scope, passed 18-0 with one excused. HB 2113 passed 18-0 with one excused. HB 2122, as amended to require hospitals to offer flu vaccines with several flexibility and critical-access-hospital exemptions, passed 15-3 with one excused. HB 2152, as amended to require certain facilities to allow medical cannabis use for qualifying terminal patients and to add related exemptions and protections, passed 17-1 with one excused. The meeting then adjourned.

Transcript Highlights:

• of the doctor-patient relationship.
• Patients that had Patients were coming in and within two, three days, they were getting better, patients
• I gave my patients my cell phone number, and Able to treat over 6,000 COVID patients.
• been treating her patient in.
• a profile on the patient portal.

Bills: SB331 , SB883 , SB926 , SB1137 , SB1138 , SB1144 , SB1151 , SB1236 , SB1270 , SB1522 , SB1869 , SB2207 , SB2422

Committee: Senate Health & Human Services

Summary: The committee heard testimony on Senate Bill 883, which would protect physicians’ ability to prescribe off-label medications and treatments, framed by the author as a “Right to Treat” measure tied to COVID-19 care. Supporters, including physicians and patient-choice advocates, said the bill would safeguard the doctor-patient relationship and prevent interference by boards, pharmacies, or hospitals. Several witnesses described using hydroxychloroquine, ivermectin, budesonide, antibiotics, steroids, and monoclonal antibodies during the pandemic, and said they faced complaints, board scrutiny, or pharmacy refusals for those prescriptions. The bill was left pending after public testimony closed. The committee then took up Senate Bill 331, which would extend hospital price-transparency requirements to additional health care facilities such as freestanding ERs, urgent care and retail clinics, ambulatory surgical centers, outpatient clinics, and birthing centers. Proponents argued that broader disclosure of prices for shoppable services would help consumers compare costs and reduce surprise billing, while opponents from ambulatory surgery centers said the bill would impose costly compliance burdens on small providers and that insurers or the state already have much of the needed data. The bill was also left pending. Senate Bill 2422 would expunge Texas Medical Board records and impose reparations for disciplinary actions tied to COVID-era treatment decisions, including references to ivermectin, hydroxychloroquine, budesonide, and masks. The author and supporters argued that doctors were unfairly targeted for trying to save patients and should be made whole; the Texas Medical Board representative said most pandemic complaints were dismissed, that actions generally involved broader issues such as privileges, documentation, or informed consent, and that no physician was disciplined solely for prescribing off-label COVID medications. The bill was left pending. Finally, the committee heard Senate Bill 2207, which would loosen Texas Medical Board rules on physicians advertising themselves as board certified, especially by reducing barriers tied to maintenance of certification requirements. Supporters said the current rule is overly restrictive, inconsistent, and costly, and that it drives physicians out of practice; they also said Texas is one of only a few states with such a rule. Witnesses described hospitals using the rule against physicians and said the change would improve transparency and competition. The bill remained pending after testimony.

Transcript Highlights:

• You know, but the behavioral health facilities need the Medicaid patients, and the Medicaid patients
• I'd like to share the story of one such patient, Mr.
• is definitely not an incentive for these patients.
• We don't wait until patients are in crisis.
• A patient navigator would contact the ELE Fund, and we would be able to provide that patient with an

Committee: Joint Joint Committee on Health Care Financing

Summary: The Joint Committee on Health Care Financing held a public hearing on a large docket of bills focused on MassHealth benefits and reimbursement, health equity, behavioral health, public health, dental access, 340B drug pricing, tobacco cessation, and coverage for children. The chairs emphasized rising health care costs, provider shortages, administrative burdens, and persistent inequities by income, race, geography, and immigration status. Much of the testimony centered on H.1416/S.901, an act to advance health equity, with legislators and members of the Health Equity Compact arguing for statewide benchmarks, stronger health equity leadership, reimbursement for interpreter services, community health workers and patient navigation, Medicaid graduate medical education support, and a health equity zone trust fund. Witnesses described disparities in life expectancy, maternal mortality, access to primary care, and the impact of federal Medicaid and social service cuts, and urged the committee to report the bill favorably. The committee also heard strong support for H.1368/S.847 on rapid whole genome sequencing for critically ill MassHealth children. Testifiers from industry, academia, hospitals, and families said early sequencing can end long diagnostic odysseys, improve treatment decisions, shorten hospital stays, and save money, while also providing emotional relief and information for families. The hearing then moved to H.1407 on MassHealth rate parity for inpatient behavioral health providers, where Rep. Scanlan and the Massachusetts Association of Behavioral Health Systems said the bill would codify existing administrative parity so managed care plans cannot pay less than the MassHealth fee-for-service rate. On H.1392/S.853 to preserve and protect public health, witnesses supported higher vaccine administration fees to improve provider participation and immunization rates. The committee also heard testimony on H.770/845 to protect 340B providers in MassHealth, and on S.848 to require reporting and transparency around 340B revenues and outside administrative costs. Additional bills drew testimony on tobacco cessation coverage for MassHealth members, with advocates supporting broader access to counseling and medications through medical, behavioral health, and dental providers. On H.1409, a nursing home operator asked for more flexibility in a MassHealth staffing-related penalty tied to patient days per resident. On H.1401/S.888, supporters of the “Take 10” dental access proposal said adult MassHealth dental coverage is underused because too few dentists accept MassHealth, leading to long travel times and avoidable emergency room visits; they urged incentive payments for dentists serving new adult MassHealth patients. Finally, on H.1403/S.855, “Cover All Kids,” advocates and immigrant community members urged removal of immigration status as a barrier to full MassHealth coverage for children, while also backing a related bill to ensure 12 months of continuous coverage for children. No votes were taken during the hearing; the committee primarily received testimony and asked questions on costs, reimbursement levels, and implementation details.

Transcript Highlights:

• ><c> and</c> patient care, treatments, and patient care, treatments, and interventions<00:04:35.280><
• : treating patients.
• ,</c><00:12:28.399><c> including</c> event for a patient, including event for a patient, including hospitalization
• Um it will help patients get forward.
• Thank you for the is treating patients.

Transcript Highlights:

• One is the patient outcomes report.
• Patient-directed medical orders address our current system's failures and give us the Patient-directed
• “It promises to enhance patient care and respect patient autonomy.
• “Thank you for your dedication to improving patient care and ensuring that patient wishes are respected
• This bill, Patient-Directed Medical Orders, lets the patient choose what they want. It's an order.

Committee: Senate Health Policy

Summary: The committee first received an update from the Department of Health on the Cancer Connect Collaborative, the Cancer Innovation Fund, and the new Cancer Connect Collaborative Research Incubator, created and expanded by recent legislation. The department reported that the Cancer Innovation Fund has awarded $80 million to 95 researchers to date, with $60 million available in the current cycle and 65 projects funded across 28 institutions in 16 cancer areas last year. The new pediatric cancer incubator received $30 million and awarded four Florida children’s hospitals $7.5 million each. Senators asked about outreach to oncologists statewide, peer review and accountability, funding for National Cancer Institute-affiliated institutions, and whether underserved and rural areas are being prioritized; the department said it uses website notices, listservs, collaborative outreach, and eligibility criteria favoring rural and high-cancer-care providers, and that it monitors projects through reports, expenditures, and contract provisions. The committee then heard Senate Bill 312 on patient-directed medical orders, which would create a voluntary, portable, physician-authorized electronic registry for patients to document end-of-life and serious-illness treatment preferences. Supporters, including nurses, hospice and emergency care advocates, and medical professionals, said the bill would help ensure patient wishes are accessible in emergencies, reduce unwanted interventions, and improve continuity of care. Opponents, including Florida Right to Life, argued the bill could broaden end-of-life decisions too far, raise privacy and coercion concerns, and allow withdrawal of care inappropriately. The sponsor said the measure is intended to support patient autonomy and is not anti-life, and noted she was open to amendments. After public testimony, the committee voted on SB 312 and reported it favorably. The roll call showed support from Senators Berman and Harrell, with the bill passing on the committee vote. The meeting then adjourned.

Transcript Highlights:

• and patient advocacy.
• And some of our most vulnerable patients, such as our cancer patients that I care for, up to 15% of individuals
• It is an ideal time to protect patients at risk, improve equity, and protect our most vulnerable patients
• more unsafe for those nurses and patients?
• is responsible for the patient from the time that the patient goes into the ambulance until they reach

Summary: The House Health Care and Wellness Committee held public hearings on several bills. HB 2152 would allow terminally ill qualifying patients to use medical cannabis in hospitals, nursing homes, and hospice facilities under facility policies that prohibit smoking/vaping, require patient self-administration and secure storage, and allow facilities to suspend compliance if federal enforcement arises. The prime sponsor and supporters, including family members, cannabis advocates, nurses, and hospital-related groups, described the bill as a compassionate end-of-life measure based on California’s Ryan’s Law; the Washington State Hospital Association asked for clarifying amendments to limit the bill to inpatient beds and to bar staff from retrieving cannabis as well as administering it. HB 2122 would require hospitals, starting in 2027 and during flu season, to offer influenza vaccines to inpatients age 65 and older and to inpatients with chronic health conditions when not contraindicated. The sponsor and supporters from diabetes, infectious disease, AARP, and public health emphasized rising flu deaths, the benefits for high-risk patients, and the chance to reduce severe illness and costs. The Washington State Hospital Association supported the goal but said the bill would create an unfunded mandate and requested amendments related to vaccine availability, emergency declarations, and operational flexibility. One witness from Informed Choice Washington opposed the bill but suggested adding vaccine information statements to strengthen informed consent. HB 2110 would change staffing rules for inter-facility specialty care ambulance transports so a registered nurse without EMT certification could satisfy the personnel requirement when no paramedic or EMT-certified nurse is available, provided an EMT-certified EMS provider is in the ambulance and the nurse has appropriate competencies. Rural hospitals and ambulance providers said the current rule delays transfers and can force long waits or air transport, while the Washington State Nurses Association supported the concept but raised concerns about standardized training, medical oversight, and staffing impacts on hospitals. HB 2113 would update radiologic technologist supervision rules for IV contrast and other procedures, allowing virtual direct supervision for contrast procedures and supervision by physicians, APRNs, or PAs in some cases; supporters said it aligns with current practice and improves rural access, while radiology groups asked for a distance/proximity requirement for virtual physician supervision. HB 2168 would require the Department of Health to rapidly share overdose data from the state EMS information system to ODMAP within 24 hours, with privacy protections and limits on law-enforcement use. Supporters from Yakima County, public health, and the poison center said near-real-time overdose mapping would improve spike alerts, prevention, and response, and could save lives; the Washington Poison Center asked that its data be included and that the bill clarify language around opioid versus other overdoses. No votes or final committee actions were taken in the hearing; the meeting ended after public testimony on HB 2168.

Transcript Highlights:

• These administrative hurdles take physicians away from their patients and can delay patient care.
• So just to kind of clarify to get to the bottom of, from the patient perspective, when a patient goes
• So just to kind of clarify to get to the bottom of, from the patient perspective, when a patient goes
• for patients and lower long-term costs...
• This patient-focused bill aims to ensure that all payments made by or on behalf of the patient are applied

Committee: Senate Health

Transcript Highlights:

• It ensures that no patient is treated unfairly.
• and he would be liable for that patient, does he still have to treat that patient and accept him, even
• and he would be liable for that patient, that that is a danger to the patient, and he would be liable
• for that patient, does he still have to treat that patient and accept him, even though he feels in his
• So it does hurt patients in that regard.

Summary: The committee met to consider a large agenda of health and human services bills, moving quickly because of a two-hour time limit. Early measures reported favorably included SB 976 on challenges to court-appointed psychologists in family law cases, SB 306 on Medicaid provider network access and after-hours availability, and SB 584 on housing supports for college students and youth in extended foster care. SB 1412 on home health regulation modernization also passed, with one support appearance from the Home Care Association. Members then approved several bills focused on research and care delivery, including SB 1800 creating a Parkinson’s disease research consortium at USF with an adopted amendment adding academic medical centers, SB 524 adding Duchenne muscular dystrophy to newborn screening, SB 1156 revising a Medicaid home health aide program for medically fragile children, and SB 1490 transferring and redesigning the managed care program for critically ill children. SB 1174 on foster home licensure transfers, SB 1620 implementing mental health and substance use commission recommendations, SB 1568 revising e-prescribing exemptions, and SB 788 on veterans nursing home beds were also reported favorably. The committee had more extensive debate on SB 1270, the Department of Health agency package, which included provisions on vaccination status, medical marijuana background screening, licensing and compact issues, and sovereign immunity for volunteer dental workers; it passed after an amendment and several members voiced concerns about patient treatment and “voting power” language. SB 1606 on patient access to records drew strong opposition from providers and health information professionals over privacy, HIPAA, and administrative burdens; it was initially reported unfavorably, then reconsidered and ultimately passed after a motion to reconsider. Other bills reported favorably included SB 1736 on insulin administration by direct support professionals and relatives, SB 1808 on patient refunds from providers, SB 1842 on referral disclosure of network status, SB 1354 on behavioral health managing entity oversight, SB 1768 on stem cell therapies with informed consent requirements, and SPB 7032 on presumptive Medicaid eligibility for permanently disabled individuals, which was submitted and reported as a committee bill. The meeting ended after all agenda items were handled and the committee adjourned.

Transcript Highlights:

• The dentist to patient ratio is 59 Dennis to 100,000 patients in the state of Florida.
• He's we treat the entire patient.
• Now, if you're looking at the medical history off these patients, so this is, again, the patients that
• So when we looked specifically at these patients, health history, almost all of them patients that have
• So those 7,500 patients UCF.

Transcript Highlights:

• These administrative hurdles take physicians away from their patients and can delay patient care.
• These administrative hurdles take physicians away from their patients and can delay patient care.
• So just to kind of clarify to get to the bottom of, from the patient perspective, when a patient goes
• So just to kind of clarify to get to the bottom of, from the patient perspective, when a patient goes
• Cost-sharing kicks in for patients.

Committee: Senate Health

Summary: The committee heard several health-related bills, beginning with SB 1124 on lung cancer screening awareness. The author and supporters said the bill would require CDPH signage about lung cancer screening eligibility at tobacco point-of-sale locations to address low awareness and low screening rates. Support came from medical students, physicians, and the California Academy of Family Physicians, while retailers raised concerns about sign size, retailer notification, and implementation. Committee members generally supported the bill and noted the need to work through those concerns. SB 1150 sought to require clearer patient notice when cancer cases are reported to the California Cancer Registry. The author described the bill as a response to inconsistent notification practices and privacy concerns, and the chair and other members shared personal stories about learning they or family members were in the registry without knowing it. Cancer registry and university stakeholders expressed appreciation for amendments but continued to have concerns or wanted more time to review the language. The bill was discussed as a patient-awareness measure rather than a change to reporting requirements. The committee also heard SB 1400 on Alameda Health System governance, SB 1094 on biosimilar substitution and health plan policies, SB 1314 on smoke shop regulation and nitrous oxide restrictions, and SB 1309 on eliminating cost-sharing for medically necessary follow-up after lung cancer screening. SB 1400 and SB 1314 drew support from local officials, labor, and public health advocates, with members emphasizing youth protection and local oversight. SB 1094 passed after extensive debate over pharmacist substitution authority and notification requirements, with a 6-0 vote and opposition from biotechnology and physician groups. SB 1309 also passed after members discussed the cost of follow-up care and the value of early detection, despite opposition from health plans over premium impacts; it received a 7-0 vote and was placed on call.

Transcript Highlights:

• </c><00:05:08.720><c> turned</c> working have ever seen a patient turned working have ever seen a patient
• </c><00:05:12.479><c> that</c> away by all means those patients that away by all means those patients
• who happens to be a Jewish patient who happens to be a Jewish patient<00:19:41.400><c> and</c><00:19
• Patients will be harmed.
• </c> information and leaving our patients information and leaving our patients stranded<00:30:09.760>

Summary: The committee heard testimony on Senate Bill 132, which would create conscience protections for health care professionals who object to participating in certain procedures or services on religious, moral, or ethical grounds. Senator Donald Douglas and several supporters argued the bill is a recruitment and retention tool for Kentucky’s health care workforce, emphasizing provider shortages, maldistribution, and the need to protect individual conscience rights. Supporters said the bill would not apply to emergency care, would not permit denial of care based on a patient’s identity, and would mainly protect professionals from being forced to perform procedures they believe are unethical. They also cited similar laws in six other states and said the bill would have a cause of action to give it enforcement teeth. Supportive testimony came from an emergency physician, a registered nurse, and others who described personal experiences or examples involving objections to abortion-related care, opioid prescribing, and pressure to participate in procedures that conflicted with conscience. They said conscience protections would help attract providers, preserve ethical integrity, and allow clinicians to make professional judgments without corporate or institutional coercion. In questioning, senators asked about practical examples, the scope of the bill, whether it would cover hypothetical cases involving patients of particular religions or identities, and which states have similar laws. The sponsor and supporters repeatedly said the bill is about procedures, not patients, and that it should not be read to allow discrimination against individuals. Opponents, including pediatricians and a registered nurse/minister, warned that the bill is overly broad and could allow refusals of care by not only physicians but also pharmacists, clerks, and ambulance drivers. They argued it could delay treatment, increase discrimination, and worsen access problems in rural areas, especially for contraception, Plan B, blood transfusions, and other services. Critics said existing professional ethics already require patient care and that the bill could undermine evidence-based medicine and worsen Kentucky’s provider shortage. The committee took testimony and questions; no final vote or disposition was announced in the portion provided.